Cargando…

Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease

The most frequent neurodegenerative illness among senior people and the main cause of dementia is Alzheimer’s disease. The present dementia medications available only help with the symptoms of cognitive deficits and have several negative effects. The current study’s goal is to assess the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Pramod, Singh, Aarti, Kumar, Anurag, Kumar, Rahul, Pal, Rishi, Sachan, Amod Kumar, Dixit, Rakesh Kumar, Nath, Rajendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216191/
https://www.ncbi.nlm.nih.gov/pubmed/37239093
http://dx.doi.org/10.3390/biomedicines11051422
_version_ 1785048239073918976
author Kumar, Pramod
Singh, Aarti
Kumar, Anurag
Kumar, Rahul
Pal, Rishi
Sachan, Amod Kumar
Dixit, Rakesh Kumar
Nath, Rajendra
author_facet Kumar, Pramod
Singh, Aarti
Kumar, Anurag
Kumar, Rahul
Pal, Rishi
Sachan, Amod Kumar
Dixit, Rakesh Kumar
Nath, Rajendra
author_sort Kumar, Pramod
collection PubMed
description The most frequent neurodegenerative illness among senior people and the main cause of dementia is Alzheimer’s disease. The present dementia medications available only help with the symptoms of cognitive deficits and have several negative effects. The current study’s goal is to assess the effects of curcumin and coenzyme Q10, two herbal medicines, both separately and in combination, on learning and memory before comparing them to the industry standard drug. A total of 42 adult healthy Wistar rats were used in our study. In this experiment, rats were given daily doses of 2.5 mg/kg of body weight of scopolamine hydrobromide for 7 days to induce Alzheimer’s disease. On the eighth day, behavioural testing was conducted. Following testing, scopolamine and the test medications were given daily for the following 21 days. On days 29 and 30, behavioural testing was conducted once more, and then animals were slaughtered. Brain homogenate was produced for the estimation of molecular and biochemical markers. Curcumin has demonstrated a dose–response relationship, with a higher dose (200 mg/kg b.w. p.o.) being more effective than a lower dose (100 mg/kg b.w. p.o.). Similar to the greater dose of curcumin, coenzyme Q10 (200 mg/kg b.w. p.o.) has also been found to improve memory and learning. Higher doses of curcumin and coenzyme Q10 had more pronounced and meaningful effects. Acetylcholinesterase and TNF levels increased in scopolamine-induced memory impairment, but these effects were restored by the test medications, and improved by the combined therapy. These outcomes are comparable to those of the common medication memantine. As a result, we may infer from our results that curcumin at higher doses and its combination with coenzyme Q10 (200 mg/kg b.w. p.o.) have a significant impact on cognitive impairment in animal models of Alzheimer’s disease and can be utilised alone or as an add-on therapy for the condition.
format Online
Article
Text
id pubmed-10216191
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102161912023-05-27 Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease Kumar, Pramod Singh, Aarti Kumar, Anurag Kumar, Rahul Pal, Rishi Sachan, Amod Kumar Dixit, Rakesh Kumar Nath, Rajendra Biomedicines Article The most frequent neurodegenerative illness among senior people and the main cause of dementia is Alzheimer’s disease. The present dementia medications available only help with the symptoms of cognitive deficits and have several negative effects. The current study’s goal is to assess the effects of curcumin and coenzyme Q10, two herbal medicines, both separately and in combination, on learning and memory before comparing them to the industry standard drug. A total of 42 adult healthy Wistar rats were used in our study. In this experiment, rats were given daily doses of 2.5 mg/kg of body weight of scopolamine hydrobromide for 7 days to induce Alzheimer’s disease. On the eighth day, behavioural testing was conducted. Following testing, scopolamine and the test medications were given daily for the following 21 days. On days 29 and 30, behavioural testing was conducted once more, and then animals were slaughtered. Brain homogenate was produced for the estimation of molecular and biochemical markers. Curcumin has demonstrated a dose–response relationship, with a higher dose (200 mg/kg b.w. p.o.) being more effective than a lower dose (100 mg/kg b.w. p.o.). Similar to the greater dose of curcumin, coenzyme Q10 (200 mg/kg b.w. p.o.) has also been found to improve memory and learning. Higher doses of curcumin and coenzyme Q10 had more pronounced and meaningful effects. Acetylcholinesterase and TNF levels increased in scopolamine-induced memory impairment, but these effects were restored by the test medications, and improved by the combined therapy. These outcomes are comparable to those of the common medication memantine. As a result, we may infer from our results that curcumin at higher doses and its combination with coenzyme Q10 (200 mg/kg b.w. p.o.) have a significant impact on cognitive impairment in animal models of Alzheimer’s disease and can be utilised alone or as an add-on therapy for the condition. MDPI 2023-05-11 /pmc/articles/PMC10216191/ /pubmed/37239093 http://dx.doi.org/10.3390/biomedicines11051422 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kumar, Pramod
Singh, Aarti
Kumar, Anurag
Kumar, Rahul
Pal, Rishi
Sachan, Amod Kumar
Dixit, Rakesh Kumar
Nath, Rajendra
Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease
title Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease
title_full Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease
title_fullStr Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease
title_full_unstemmed Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease
title_short Effect of Curcumin and Coenzyme Q10 Alone and in Combination on Learning and Memory in an Animal Model of Alzheimer’s Disease
title_sort effect of curcumin and coenzyme q10 alone and in combination on learning and memory in an animal model of alzheimer’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216191/
https://www.ncbi.nlm.nih.gov/pubmed/37239093
http://dx.doi.org/10.3390/biomedicines11051422
work_keys_str_mv AT kumarpramod effectofcurcuminandcoenzymeq10aloneandincombinationonlearningandmemoryinananimalmodelofalzheimersdisease
AT singhaarti effectofcurcuminandcoenzymeq10aloneandincombinationonlearningandmemoryinananimalmodelofalzheimersdisease
AT kumaranurag effectofcurcuminandcoenzymeq10aloneandincombinationonlearningandmemoryinananimalmodelofalzheimersdisease
AT kumarrahul effectofcurcuminandcoenzymeq10aloneandincombinationonlearningandmemoryinananimalmodelofalzheimersdisease
AT palrishi effectofcurcuminandcoenzymeq10aloneandincombinationonlearningandmemoryinananimalmodelofalzheimersdisease
AT sachanamodkumar effectofcurcuminandcoenzymeq10aloneandincombinationonlearningandmemoryinananimalmodelofalzheimersdisease
AT dixitrakeshkumar effectofcurcuminandcoenzymeq10aloneandincombinationonlearningandmemoryinananimalmodelofalzheimersdisease
AT nathrajendra effectofcurcuminandcoenzymeq10aloneandincombinationonlearningandmemoryinananimalmodelofalzheimersdisease